2022 PCF TACTICAL Awards (Therapy ACceleration To Intercept CAncer Lethality). Targeting Mechanisms of Lethal Prostate Cancer

DEPARTMENT OF DEFENSE USA - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS

Objecte

Topic: Prostate cancer.

Destination: Request for LOIs for PCF TACTICAL Awards from qualified teams of academic scientists that will specifically address the development of 21st Century therapies for lethal forms of prostate cancer. These awards will be funded depending on the level of innovation in applications received. PCF seeks high-risk, currently unfunded projects from academic institutions around the world. Clinical trial costs are not allowed; however, correlative research to support high impact clinical trials for advanced prostate cancer is encouraged.

Budget: $5 –10 M.

Duration: 3 years.

Are you interested in this call?

Estàs interessat?

Omple el següent formulari per rebre més informació: